Memowell
Memowell, licence 80107357: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Kondor Pharma Inc.
- NPN or DIN-HM
- 80107357
- Status
- Active licence
- Licence date
- 18 January 2021
- Revision date
- 22 October 2021
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
- Dose déclarée au-delà d'une limite
Vitamine D: up to 24.96 µg a day according to the dosing instructions published by Health Canada (3 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 5 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Boswellia serrata Source : Boswellia serrata - Oléorésine (écorce de tronc) Extract : Matériel brut sec Extraction ratio : 8:1 Dry plant equivalent : 2664 mg Potency : 40.0 % Boswellic acids | 333.0 mg | Not calculated |
| Bacopa monnieri Source : Sommité Extract : Matériel brut sec Extraction ratio : 3:1 Dry plant equivalent : 300 mg Potency : 50.0 % Bacosides A and B | 100.0 mg | Not calculated |
| Vitamine D Source : Cholécalciférol | 8.32 microgram | 24.96 µg |
Non-medicinal ingredients
Cellulose, NA, Stéarate de magnésium, Lécithine, Hypromellose, Dioxyde de silicium, Silicate de calcium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19.0 Année(s) | 1.0 Capsule | 3.0 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps to relieve joint pain and swelling associated with osteoarthritis of the knee. Helps support cognitive health and/or brain function. Helps support memory. Contributes to maintaining general health. For maintaining general health. Helps (to) maintain/support immune function/system. Helps in the absorption (and use) of calcium and phosphorus. Helps in the development and maintenance of bones and teeth. Helps to build strong bones and teeth. Helps to prevent vitamin D deficiency. Helps with immune function. Maintains good health. Supports good health. Vitamin supplement.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80107357
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2021. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.